The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included approximately 800 older men with low testosterone and symptoms associated with this affliction, like http://tinyurl.com/jrdad8y
sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.
Research has shown that testosterone deficiency is related to a number of important health problems such as diabetes, obesity, metabolic syndrome, and bone fractures
Men who meet medical standards for treatment should get therapy. In fact, your testosterone levels have likely been slowly decreasing for quite some time, a downfall that usually begins around age 30.
And many women have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. However, clinical studies show that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser believes
this will likely remain the status quo for some time, given the prohibitive cost of conducting the long-term safety studies needed to win completer FDA acceptance.